Precigen Net Worth

Precigen Net Worth Breakdown

  PGEN
The net worth of Precigen is the difference between its total assets and liabilities. Precigen's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Precigen's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Precigen's net worth can be used as a measure of its financial health and stability which can help investors to decide if Precigen is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Precigen stock.

Precigen Net Worth Analysis

Precigen's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Precigen's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Precigen's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Precigen's net worth analysis. One common approach is to calculate Precigen's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Precigen's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Precigen's net worth. This approach calculates the present value of Precigen's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Precigen's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Precigen's net worth. This involves comparing Precigen's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Precigen's net worth relative to its peers.

Enterprise Value

310.84 Million

To determine if Precigen is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Precigen's net worth research are outlined below:
Precigen generated a negative expected return over the last 90 days
Precigen has some characteristics of a very speculative penny stock
Precigen has high historical volatility and very poor performance
The company reported the previous year's revenue of 6.22 M. Net Loss for the year was (95.9 M) with profit before overhead, payroll, taxes, and interest of 20.57 M.
Precigen currently holds about 115.3 M in cash with (66.93 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.55.
Precigen has a poor financial position based on the latest SEC disclosures
Roughly 64.0% of the company shares are owned by institutional investors
Latest headline from simplywall.st: Insiders Sold Precigen Prematurely At US1.41 With Stock Trading Higher

Precigen Quarterly Good Will

24.92 Million

Precigen uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Precigen. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Precigen's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
4th of March 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Know Precigen's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Precigen is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Precigen backward and forwards among themselves. Precigen's institutional investor refers to the entity that pools money to purchase Precigen's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Northern Trust Corp2024-09-30
M
Gmt Capital Corp2024-06-30
668.8 K
Nuveen Asset Management, Llc2024-06-30
535 K
Emfo, Llc2024-06-30
519.5 K
Tang Capital Management Llc2024-09-30
500 K
Clarivest Asset Management Llc2024-06-30
492.2 K
Bank Of New York Mellon Corp2024-06-30
421.8 K
Advisor Group Holdings, Inc.2024-06-30
408.3 K
Citadel Advisors Llc2024-09-30
383 K
Patients Capital Management Llc2024-09-30
17.9 M
Blackrock Inc2024-06-30
10.2 M
Note, although Precigen's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Precigen's market capitalization trends

The company currently falls under 'Small-Cap' category with a current market capitalization of 251.84 M.

Market Cap

311.29 Million

Project Precigen's profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(1.15)(1.20)
Return On Capital Employed(0.69)(0.73)
Return On Assets(0.63)(0.67)
Return On Equity(0.81)(0.85)
When accessing Precigen's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Precigen's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Precigen's profitability and make more informed investment decisions.

Evaluate Precigen's management efficiency

Precigen has return on total asset (ROA) of (0.4232) % which means that it has lost $0.4232 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2932) %, meaning that it created substantial loss on money invested by shareholders. Precigen's management efficiency ratios could be used to measure how well Precigen manages its routine affairs as well as how well it operates its assets and liabilities. As of the 28th of November 2024, Return On Tangible Assets is likely to drop to -1.2. In addition to that, Return On Capital Employed is likely to drop to -0.73. At this time, Precigen's Non Currrent Assets Other are very stable compared to the past year. As of the 28th of November 2024, Intangible Assets is likely to grow to about 78.7 M, while Total Assets are likely to drop about 143.5 M.
Last ReportedProjected for Next Year
Book Value Per Share 0.48  0.51 
Tangible Book Value Per Share 0.21  0.22 
Enterprise Value Over EBITDA(3.67)(3.85)
Price Book Value Ratio 2.77  4.45 
Enterprise Value Multiple(3.67)(3.85)
Price Fair Value 2.77  4.45 
Enterprise Value327.2 M310.8 M
Precigen benefits from a proactive management team that anticipates market trends. Our analysis delves into how this proactive stance influences financial metrics and stock valuation.
Enterprise Value Revenue
57.7734
Revenue
4.4 M
Quarterly Revenue Growth
(0.59)
Revenue Per Share
0.018
Return On Equity
(1.29)
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Precigen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Precigen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Precigen insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Precigen time-series forecasting models is one of many Precigen's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Precigen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Precigen Earnings per Share Projection vs Actual

Precigen Corporate Management

Rob RussellVP ResourcesProfile
Mr JDChief SecretaryProfile
Donald LehrChief SecretaryProfile
Rutul ShahChief OfficerProfile
Jeffrey PerezSenior AffairsProfile
Jeffrey JDSenior AffairsProfile
When determining whether Precigen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Precigen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Precigen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Precigen Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Precigen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
To learn how to invest in Precigen Stock, please use our How to Invest in Precigen guide.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precigen. If investors know Precigen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precigen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.54)
Revenue Per Share
0.018
Quarterly Revenue Growth
(0.59)
Return On Assets
(0.42)
Return On Equity
(1.29)
The market value of Precigen is measured differently than its book value, which is the value of Precigen that is recorded on the company's balance sheet. Investors also form their own opinion of Precigen's value that differs from its market value or its book value, called intrinsic value, which is Precigen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precigen's market value can be influenced by many factors that don't directly affect Precigen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precigen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Precigen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precigen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.